Go Pro
→ The dollar reset no one told you about (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$183.17
+0.7%		$157.84
$127.59
▼
$187.35
$50.53B0.191.89 million shs1.01 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$91.51
-1.1%		$88.73
$72.30
▼
$96.29
$52.74B0.854.60 million shs2.86 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$76.01
$75.56
$51.90
▼
$76.07
$16.97B0.73.29 million shs102.03 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$550.96
-2.8%		$561.04
$518.55
▼
$769.98
$43.41B1.54614,175 shs530,335 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.00%+3.76%+14.58%+27.80%-6.60%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.00%+2.07%+4.08%+12.50%+17.79%
Hologic, Inc. stock logo
HOLX
Hologic
0.00%0.00%0.00%0.00%+10.19%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.00%-6.09%-4.36%+4.19%-17.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$183.17
+0.7%		$157.84
$127.59
▼
$187.35
$50.53B0.191.89 million shs1.01 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$91.51
-1.1%		$88.73
$72.30
▼
$96.29
$52.74B0.854.60 million shs2.86 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$76.01
$75.56
$51.90
▼
$76.07
$16.97B0.73.29 million shs102.03 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$550.96
-2.8%		$561.04
$518.55
▼
$769.98
$43.41B1.54614,175 shs530,335 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.00%+3.76%+14.58%+27.80%-6.60%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.00%+2.07%+4.08%+12.50%+17.79%
Hologic, Inc. stock logo
HOLX
Hologic
0.00%0.00%0.00%0.00%+10.19%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.00%-6.09%-4.36%+4.19%-17.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.41
Hold$185.671.37% Upside
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.74
Moderate Buy$100.279.58% Upside
Hologic, Inc. stock logo
HOLX
Hologic
2.00
Hold$79.134.10% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.60
Moderate Buy$747.0035.58% Upside

Current Analyst Ratings Breakdown

Latest HOLX, EW, BDX, and IDXX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/13/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$180.00 ➝ $190.00
8/11/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$800.00 ➝ $710.00
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$195.00
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$175.00 ➝ $180.00
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform ➝ Hold
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$198.00 ➝ $204.00
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$161.00 ➝ $175.00
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$161.00 ➝ $170.00
8/6/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$210.00
(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$22.48B2.24$23.04 per share7.95$88.61 per share2.07
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$6.07B8.68$2.85 per share32.12$18.63 per share4.91
Hologic, Inc. stock logo
HOLX
Hologic
$4.10B4.14$5.74 per share13.25$22.69 per share3.35
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$4.30B10.09$15.09 per share36.52$20.47 per share26.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.68B$3.3255.1713.8012.934.52%14.79%6.93%N/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$1.07B$1.7452.5927.072.3015.43%15.68%12.05%10/29/2026 (Estimated)
Hologic, Inc. stock logo
HOLX
Hologic
$565.70M$2.4031.6716.452.2413.18%19.58%10.88%N/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$1.06B$14.2238.7533.152.9425.03%71.96%33.60%11/2/2026 (Estimated)

Latest HOLX, EW, BDX, and IDXX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q3 2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.14$3.23+$0.09$1.37$4.89 billion$4.98 billion
8/4/2026Q2 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.94$4.27+$0.33$4.27$1.20 billion$1.22 billion
7/23/2026Q2 2026
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.7430$0.78+$0.0370$0.42$1.70 billion$1.74 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.202.29%+5.65%126.51%53 Years
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A

Latest HOLX, EW, BDX, and IDXX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.052.53%9/9/20269/9/20269/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.55
0.87
0.51
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.52
3.77
Hologic, Inc. stock logo
HOLX
Hologic
0.48
4.04
3.32
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.19
1.17
0.87

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.40%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.31%
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.79%
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
72,000275.54 million274.44 millionOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
16,000575.80 million574.02 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,070223.24 million219.05 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00078.78 million78.16 millionOptionable

Recent News About These Companies

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30963454
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/idexx-laboratories-inc-nasdaqidxx-receives-average-rating-of-moderate-buy-from-analysts-2026-08-16/
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests
August 14 at 2:02 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/idexx-laboratories-targets-45b-pet-diagnostics-opportunity-with-ai-cancer-tests-2026-08-14/
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day - Slideshow
August 14 at 1:34 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4936889-idexx-laboratories-inc-idxx-analyst-investor-day-slideshow
Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX
August 13 at 5:20 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-handelsbanken-fonder-ab-grows-position-in-idexx-laboratories-inc-idxx-2026-08-13/
Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/strong-q2-2026-results-cardiac-021011441.html
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973463/here-s-why-idexx-laboratories-idxx-is-a-strong-growth-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_growth_score-2973463
NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-newedge-advisors-llc-acquires-5761-shares-of-idexx-laboratories-inc-idxx-2026-08-10/
Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-seilern-investment-management-ltd-purchases-16729-shares-of-idexx-laboratories-inc-idxx-2026-08-09/
IDEXX Laboratories: Worth The Premium
August 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933707-idexx-laboratories-worth-the-premium?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by Beacon Investment Advisory Services Inc.
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-idexx-laboratories-inc-idxx-shares-sold-by-beacon-investment-advisory-services-inc-2026-08-08/
Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-aurora-investment-managers-llc-makes-new-investment-in-idexx-laboratories-inc-idxx-2026-08-08/
Assenagon Asset Management S.A. Boosts Position in IDEXX Laboratories, Inc. $IDXX
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-assenagon-asset-management-sa-boosts-position-in-idexx-laboratories-inc-idxx-2026-08-08/
Janus Henderson Group PLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-janus-henderson-group-plc-cuts-stock-holdings-in-idexx-laboratories-inc-idxx-2026-08-07/
Citi Keeps Their Hold Rating on Idexx Laboratories (IDXX)
August 6, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/IDXX/pressreleases/3687424/citi-keeps-their-hold-rating-on-idexx-laboratories-idxx/
Here is Why Growth Investors Should Buy Idexx (IDXX) Now
August 6, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970282/here-is-why-growth-investors-should-buy-idexx-idxx-now?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_11_growth-2970282
IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary
August 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/idexx-laboratories-inc-q2-2026-221532904.html
IDEXX Laboratories (NASDAQ:IDXX) Given New $670.00 Price Target at UBS Group
August 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30944449
IDEXX Laboratories, Inc. $IDXX Shares Sold by Empowered Funds LLC
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-idexx-laboratories-inc-idxx-shares-sold-by-empowered-funds-llc-2026-08-06/
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, UBS Group Analyst Says
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/idexx-laboratories-nasdaqidxx-stock-price-expected-to-rise-ubs-group-analyst-says-2026-08-05/
IDEXX Laboratories jumps 5% on strong results, raised guidance
August 4, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/idexx-laboratories-jumps-5-on-strong-results-raised-guidance/ar-AA29oIle

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
A Patriot missile launcher and soldier on an airbase tarmac as an F-35 fighter jet flies overhead at sunset.
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
Illustration of a Truth Social post streaming as data to trading monitors and a smartphone in an office setting.
Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
By Jeffrey Neal Johnson | July 22, 2026
AMD logo centered on a futuristic circuit-board background with soft blue and red glow accents.
Microsoft's AI Bet Could Rewrite AMD's Growth Story
By Jeffrey Neal Johnson | July 21, 2026
AMD and Cerebras logos connected by glowing cables between server hardware racks in a data center.
AMD and Cerebras Create A New Blueprint For Hardware
By Jeffrey Neal Johnson | July 24, 2026
Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$183.16 +1.20 (+0.66%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$183.40 +0.24 (+0.13%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$91.51 -1.05 (-1.13%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$91.50 -0.01 (-0.01%)
As of 08/14/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Hologic stock logo

Hologic NASDAQ:HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$550.96 -15.97 (-2.82%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$557.10 +6.13 (+1.11%)
As of 08/14/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas